Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Indiqube Spaces Ltd

INDIQUBE
Miscellaneous

Indiqube Spaces Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.

The price is in a downtrend (34 weeks in). Underneath, the last four quarters read improving. What settles it: the next one or two quarters of delivery.

Price
₹174
−20.2% 1Y
Revenue (Mar 26)
₹401 Cr
+35.0% YoY
Profit (Mar 26)
₹−23.0 Cr
Operating margin
62.0%
+5.0 pp YoY
ROCE
6%
FY26
Withheld from this page: Part of this page is deliberately not drawn: its two data sources disagree by up to 6.0% on reported income across 8 comparable periods, so nothing from the second source is placed here — the quarterly return curves, the total-debt and debt-to-equity series and the F-score and the return-on-invested-capital reading are absent for that reason. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Indiqube Spaces Ltd trades at ₹174, in a downtrend and 34 weeks into that stage. That is −3.4% against its own 200-day average. It sits at 39% of a 52-week range of ₹134 to ₹238. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks.

Today the stock is in a downtrend — week 34 of stage 4, confirmed. At ₹174 it trades −3.4% versus its 200-day average and sits at 39% of its 52-week range (₹134–₹238).

Jul 26: ₹174 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
−3.4% versus the 200-day line, week 34 of stage 4
Price50-day avg200-day avg
S4S1S2S4₹246₹216₹186₹155₹125₹174₹180Aug 25Oct 25Feb 26May 26Jul 26
S4S1S2S4₹246₹216₹186₹155₹125₹174₹180Aug 25Feb 26Jul 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (56 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Aug 25Jul 26

Against the market, two honest reads. Cumulative: over the last 1.0 years the stock moved −20% while the NIFTY 500 moved +4% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

P/E does not price Indiqube Spaces Ltd — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. On sales the market values Indiqube Spaces Ltd at 2.5× its FY26 revenue of ₹1,451 Cr.

With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.

P/E
earnings negative

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Indiqube Spaces Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue +37.0% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
73%58%43%28%13%%37%FY20FY23FY26
73%58%43%28%13%%37%FY20FY23FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
Revenue
47%42%37%31%26%%35%Jun 24Mar 25Mar 26
47%42%37%31%26%%35%Jun 24Mar 25Mar 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
6.8%3.9%1.0%−1.9%−4.8%%6%FY23FY24FY26
6.8%3.9%1.0%−1.9%−4.8%%6%FY23FY24FY26
ROCE
Rising
latest 6.0% · span −4.0%–6.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+37.0%+35.8%+37.6%
Share price−20.2%
Revenue YoY (Mar 26)
+35.0%
latest quarter vs a year ago
Revenue 10y
35.0%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

49.3/100 — rank 33 of 36 in Miscellaneous · 46% evidence confidence · provisional, ranked below fully-evidenced peers

Indiqube Spaces Ltd scores 49.3 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 33. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 20.9 + 9.6 + 10 + 8.8 = 49.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Indiqube Spaces Ltd reported ₹401 Cr of revenue in the Mar 26 quarter, +35.0% year on year. That is the 4th straight quarter of year-on-year growth. Over 6 years it has compounded at 35.0% a year. The last full year, FY26, came in at ₹1,451 Cr. The last four reported quarters add to ₹1,450 Cr.

FY26 revenue came in at ₹1,451 Cr (+37.0% on the year), capping 6 years at 35.0% compound. The latest quarter (Mar 26) printed ₹401 Cr, +35.0% year on year — the 4th consecutive quarter of year-over-year growth.

FY26 revenue ₹1,451 Cr (+37.0% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 7-year window. A bar is red when it is lower than the year before.
35.0% a year over 6 years
RevenueYoY growth
1.6k73%1.2k58%78443%39228%013%₹ Cr%₹1,45137%FY20FY23FY26
1.6k73%1.2k58%78443%39228%013%₹ Cr%₹1,45137%FY20FY23FY26
Mar 26: ₹401 Cr (+35.0% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
4th straight quarter of growth
Revenue (quarterly)YoY growth
43347%32542%21737%10831%026%₹ Cr%₹40135%Jun 24Mar 25Mar 26
43347%32542%21737%10831%026%₹ Cr%₹40135%Jun 24Mar 25Mar 26

Pace check: the last four quarters averaged +36.8% growth against the decade's 35.0% — the current year is running faster than its own long-run rate.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Indiqube Spaces Ltd's operating margin is 62.0% in the Mar 26 quarter, +5.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 7 fiscal years the operating margin has ranged 10.0% to 61.0%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 62.0%, +5.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 10.0%–61.0%, and FY26's 61.0% is the top of that band — a record year.

Why the margin moved: operating margin went +4.5 pp year on year while gross margin went −0.8 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY26: 61.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 7-year window.
the widest a 10.0–61.0% band over 7 years
operating marginYoY change (pp)
65%35%50%22%36%8.5%21%−4.6%5.9%−18%%%61%3%FY20FY23FY26
65%35%50%22%36%8.5%21%−4.6%5.9%−18%%%61%3%FY20FY23FY26
Mar 26: 62.0% operating margin (+5.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
62%5.2%61%4.4%60%3.5%58%2.6%57%1.8%%%62%5%Jun 24Mar 25Mar 26
62%5.2%61%4.4%60%3.5%58%2.6%57%1.8%%%62%5%Jun 24Mar 25Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Indiqube Spaces Ltd posted a net loss of ₹23.0 Cr in the Mar 26 quarter. The full FY26 year was a loss of ₹106 Cr. That loss is 5.7% of the quarter's revenue. The same quarter a year earlier lost ₹31.0 Cr. 8 of the last 8 reported quarters were loss-making.

Mar 26 profit was ₹−23.0 Cr, null year on year. On the full year, FY26 printed ₹−106 Cr (null).

FY26 profit ₹−106 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 7-year window. A bar is red when it is lower than the year before.
Net profit
27−72−171−270−369₹ Cr₹−106FY20FY23FY26
27−72−171−270−369₹ Cr₹−106FY20FY23FY26
Mar 26: ₹−23.0 Cr (null YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
4−11−27−42−57₹ Cr₹−23Jun 24Mar 25Mar 26
4−11−27−42−57₹ Cr₹−23Jun 24Mar 25Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Indiqube Spaces Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was ₹920 Cr of operating cash against ₹−106 Cr of profit. After ₹1,885 Cr of capital spending, ₹−965 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY26: operating cash of ₹920 Cr against reported profit of ₹−106 Cr, leaving free cash of ₹−965 Cr after ₹1,885 Cr of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹920 Cr vs profit ₹−106 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 7-year window, annual resolution. FY22 reflects an acquisition year — point shown clipped.
Operating cashNet profitFree cash
1.1k524−23−569−1.1k₹ Cr₹920₹−106₹−965FY20FY23FY26
1.1k524−23−569−1.1k₹ Cr₹920₹−106₹−965FY20FY23FY26
FY26: CFO = Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
of profit
100%
101.2%100.6%100.0%99.4%98.8%%FY20FY23FY26
101.2%100.6%100.0%99.4%98.8%%FY20FY23FY26

Router verdict: the bigger cash user is investment — capital spending ran 2.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Indiqube Spaces Ltd's cash conversion cycle runs −273 days in FY26, down from 26 days in FY21. Capital spending ran ₹4,263 Cr over the last 3 years. At FY26 sales of ₹1,451 Cr each day of that cycle holds about ₹4.0 Cr, so roughly ₹−1,085 Cr sits inside the business at any moment.

FY26: debtors at 28 days, inventory at 3 days — roughly 0.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −273 days, tighter than FY21's 26.

The full loop: cash goes out to suppliers and production on day 0; stock waits 3 days to sell; customers pay about 28 days after that; and suppliers themselves are paid at 304 days — netting out to the −273-day cycle.

In money terms: at FY26 sales of ₹1,451 Cr, each day of the cycle holds about ₹4.0 Cr — so the −273-day loop keeps roughly ₹−1,085 Cr sitting inside the business at any moment.

FY26: a −273-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 7-year window.
−299 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
35018316−152−319days−273d3d28d304dFY20FY21FY23FY24FY26
35018316−152−319days−273d3d28d304dFY20FY23FY26

On the investment side: capital spending of ₹4,263 Cr over the last 3 fiscal years against ₹1,524 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹96.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹1,885 Cr, work-in-progress ₹96.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
2.2k1.6k1.1k5440₹ Cr₹1,885₹96FY21FY22FY23FY24FY26
2.2k1.6k1.1k5440₹ Cr₹1,885₹96FY21FY23FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Indiqube Spaces Ltd earns a ROCE of 6% in FY26. That is up from a trough of −7% in FY22. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −7.3% net margin on 0.22× asset turns.

FY26 ROCE is 6%, recovered from a FY22 trough of −7% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): −7.3% net margin × 0.22× asset turns × 12.64× balance-sheet leverage ≈ −20.3% on equity. Margin does its share; leverage is a meaningful part of the equation.

FY26: ROCE 6% Return on capital employed by fiscal year, % (line). 6-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY22's −7%
ROCEWACC
14%8.0%2.5%−3.0%−8.5%%6%FY21FY22FY23FY24FY26
14%8.0%2.5%−3.0%−8.5%%6%FY21FY23FY26

The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 6.0% on reported income across 8 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

Indiqube Spaces Ltd carries ₹5,207 Cr of borrowings against ₹515 Cr of equity in FY26, a debt-to-equity of 10.11. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹154 Cr to ₹5,207 Cr. Capital spending ran ₹4,263 Cr across the last 3 of those years.

FY26: borrowings of ₹5,207 Cr against equity of ₹515 Cr — a debt-to-equity of 10.11. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹154 Cr to ₹5,207 Cr while capital spending ran ₹4,263 Cr in just the last 3 — part of the build-out is riding on borrowed money.

FY26: borrowings ₹5,207 Cr at 10.11× equity Borrowings by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 7-year window. Quarterly balance-sheet history is not held for India — annual is the honest resolution.
the debt trajectory
BorrowingsDebt-to-equity
5.6k58.3×4.2k−67.3×2.8k−192.9×1.4k−318.5×0−444.1×₹ Cr×₹5,20710.11×FY20FY21FY23FY24FY26
5.6k58.3×4.2k−67.3×2.8k−192.9×1.4k−318.5×0−444.1×₹ Cr×₹5,20710.11×FY20FY23FY26

The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 6.0% on reported income across 8 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Indiqube Spaces Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — .

A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 4 quarters.
PromotersForeign inst.Domestic inst.Public
65%48%31%14%−2.5%%60.1%2.2%14.3%23.4%Sep 25Dec 25Jun 26
65%48%31%14%−2.5%%60.1%2.2%14.3%23.4%Sep 25Dec 25Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Indiqube Spaces Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Miscellaneous
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1IIRM Holdings India Ltd526530 66.2/100Favorable setup71% evidence LEADER 17.7/35 Revenue 14.9% · PAT 12.7% · OPM change 8.4 pp 83% evidence 19.1/25 ROCE 20.4% · OPM 24.8% 76% evidence 9.7/20 P/E 40.4× · PEG — 15% evidence 19.7/20 RS sector 49.6% · RS bench 53.5% · 1Y 67.5%12 of 12 weeks ahead 100% evidence
Exact sum: 17.7 + 19.1 + 9.7 + 19.7 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Sagility LtdSAGILITY 66.1/100Favorable setup87% evidence TURNING 24.4/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence 15.5/25 ROCE 13.4% · OPM 22% 100% evidence 14.2/20 P/E 19.8× · PEG 1.05 65% evidence 12.0/20 RS sector 7.2% · RS bench -5% · 1Y -1.2%0 of 10 weeks ahead 70% evidence
Exact sum: 24.4 + 15.5 + 14.2 + 12 = 66.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Gulshan Polyols LtdGULPOLY 65.2/100Favorable setup75% evidence TURNING 24.8/35 Revenue 35.2% · PAT 87% · OPM change 4.3 pp 59% evidence 12.3/25 ROCE 6.3% · OPM 8% 95% evidence 10.5/20 P/E 28.9× · PEG — 50% evidence 17.6/20 RS sector 16.1% · RS bench 19.4% · 1Y 16.1%10 of 12 weeks ahead 100% evidence
Exact sum: 24.8 + 12.3 + 10.5 + 17.6 = 65.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Exhicon Events Media Solutions Ltd543895 64.4/100Thin evidence · provisional60% evidence ASLEEP 19.3/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence 20.1/25 ROCE 29.5% · OPM 28% 76% evidence 13.6/20 P/E 19.2× · PEG — 50% evidence 11.4/20 RS sector 2.2% · RS bench -1.2% · 1Y -7.8%0 of 10 weeks ahead 70% evidence
Exact sum: 19.3 + 20.1 + 13.6 + 11.4 = 64.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5GMR Airports LtdGMRAIRPORT 59.8/100Mixed-positive evidence71% evidence BREAKING OUT 22.8/35 Revenue 42.2% · PAT 100% · OPM change 2 pp 65% evidence 14.2/25 ROCE 11.6% · OPM 37% 100% evidence 8.6/20 P/E 534× · PEG — 15% evidence 14.2/20 RS sector 3.3% · RS bench 6.5% · 1Y 17.1%9 of 12 weeks ahead 100% evidence
Exact sum: 22.8 + 14.2 + 8.6 + 14.2 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Aeroflex Enterprises LtdAEROENTER 59.3/100Mixed-positive evidence83% evidence LEADER 16.8/35 Revenue 20.4% · PAT 4.9% · OPM change 1 pp 83% evidence 16.0/25 ROCE 12.6% · OPM 18% 95% evidence 8.1/20 P/E 20.9× · PEG — 50% evidence 18.4/20 RS sector 24.8% · RS bench 28.1% · 1Y 16%12 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 16 + 8.1 + 18.4 = 59.3 · Decision use: Price leads the evidence: RS versus the benchmark is 28.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7Global Education LtdGLOBAL 59.3/100Mixed-positive evidence76% evidence ASLEEP 16.6/35 Revenue 29.9% · PAT -5.5% · OPM change 7.5 pp 83% evidence 19.4/25 ROCE 29.2% · OPM 47% 95% evidence 10.8/20 P/E 20× · PEG — 15% evidence 12.5/20 RS sector 12.5% · RS bench 15.9% · 1Y 56.5%1 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 19.4 + 10.8 + 12.5 = 59.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Take Solutions LtdTAKE 58.9/100Mixed-positive evidence63% evidence 25.1/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence 8.3/25 ROCE 11.2% · OPM — 80% evidence 8.5/20 P/E 3222× · PEG — 15% evidence 17.0/20 RS sector 68% · RS bench 71.4% · 1Y 305.2%11 of 12 weeks ahead to 2026-05-03 100% evidence
Exact sum: 25.1 + 8.3 + 8.5 + 17 = 58.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9R K Swamy LtdRKSWAMY 58.5/100Mixed-positive evidence61% evidence TURNING 22.5/35 Revenue 15.9% · PAT 21.1% · OPM change 3 pp 83% evidence 16.9/25 ROCE 12.3% · OPM 22% 95% evidence 10.4/20 P/E 21.2× · PEG — 15% evidence 8.7/20 RS sector — · RS bench -11.2% · 1Y —3 of 3 weeks ahead 25% evidence
Exact sum: 22.5 + 16.9 + 10.4 + 8.7 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Jai Corp LtdJAICORPLTD 57.6/100Mixed-positive evidence70% evidence ASLEEP 24.1/35 Revenue -0.6% · PAT 100% · OPM change 5 pp 83% evidence 15.3/25 ROCE 13.3% · OPM 13% 95% evidence 11.5/20 P/E 10.4× · PEG — 15% evidence 6.7/20 RS sector -8.2% · RS bench -18.9% · 1Y -1.9%4 of 10 weeks ahead 70% evidence
Exact sum: 24.1 + 15.3 + 11.5 + 6.7 = 57.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.2% and the one-year return is -1.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
11Aegis Vopak Terminals LtdAEGISVOPAK 56.0/100Thin evidence · provisional56% evidence TURNING 21.4/35 Revenue 25.6% · PAT 76.7% · OPM change 2 pp 83% evidence 13.4/25 ROCE 7.6% · OPM 74% 76% evidence 9.1/20 P/E 104× · PEG — 15% evidence 12.1/20 RS sector — · RS bench 22% · 1Y 13%5 of 10 weeks ahead 25% evidence
Exact sum: 21.4 + 13.4 + 9.1 + 12.1 = 56 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Parin Enterprises LtdPARIN 54.3/100Mixed-positive evidence63% evidence BREAKING OUT 19.7/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 11.7/25 ROCE 10.8% · OPM 9% 95% evidence 9.0/20 P/E 123× · PEG — 15% evidence 13.9/20 RS sector 13.1% · RS bench 16.5% · 1Y 94.6%7 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 11.7 + 9 + 13.9 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Inox Green Energy Services LtdINOXGREEN 50.7/100Mixed-positive evidence65% evidence ASLEEP 24.7/35 Revenue 24.6% · PAT 100% · OPM change 0.5 pp 83% evidence 9.5/25 ROCE 8.4% · OPM -4.1% 76% evidence 9.3/20 P/E 66× · PEG — 15% evidence 7.2/20 RS sector -8.6% · RS bench -8.4% · 1Y -1.1%6 of 10 weeks ahead 70% evidence
Exact sum: 24.7 + 9.5 + 9.3 + 7.2 = 50.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Eveready Industries India LtdEVEREADY 48.3/100Mixed-negative evidence90% evidence TURNING 17.6/35 Revenue 8.2% · PAT 100% · OPM change 0 pp 88% evidence 14.9/25 ROCE 17.2% · OPM 9% 100% evidence 8.1/20 P/E 24.9× · PEG 2.1 100% evidence 7.7/20 RS sector -9.5% · RS bench -3% · 1Y -19.9%4 of 10 weeks ahead 70% evidence
Exact sum: 17.6 + 14.9 + 8.1 + 7.7 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15TCC Concept LtdTCC 47.3/100Mixed-negative evidence81% evidence ASLEEP 17.3/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence 11.4/25 ROCE 5.7% · OPM 36% 95% evidence 14.1/20 P/E 20.9× · PEG — 50% evidence 4.5/20 RS sector -17.6% · RS bench -35% · 1Y -44.2%0 of 11 weeks ahead 70% evidence
Exact sum: 17.3 + 11.4 + 14.1 + 4.5 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16GKW LtdGKWLIMITED 46.7/100Mixed-negative evidence63% evidence ASLEEP 20.7/35 Revenue -2.1% · PAT 87.5% · OPM change 2160.4 pp 83% evidence 6.7/25 ROCE 0.5% · OPM — 80% evidence 10.0/20 P/E — · PEG — 0% evidence 9.3/20 RS sector -0.9% · RS bench -5% · 1Y -8.8%4 of 10 weeks ahead 70% evidence
Exact sum: 20.7 + 6.7 + 10 + 9.3 = 46.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Prozone Realty LtdPROZONER 43.4/100Mixed-negative evidence68% evidence ASLEEP 21.2/35 Revenue 9.2% · PAT 100% · OPM change 23 pp 62% evidence 11.2/25 ROCE 6.1% · OPM 34.5% 95% evidence 9.6/20 P/E 59.4× · PEG — 15% evidence 1.4/20 RS sector -23% · RS bench -20.5% · 1Y -0.5%2 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 11.2 + 9.6 + 1.4 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Jindal Photo LtdJINDALPHOT 41.5/100Mixed-negative evidence67% evidence ASLEEP 14.6/35 Revenue 100% · PAT -80% · OPM change -1015.9 pp 83% evidence 5.9/25 ROCE -1.4% · OPM -932.6% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 11.0/20 RS sector 6.3% · RS bench -13.8% · 1Y 23.1%0 of 10 weeks ahead 70% evidence
Exact sum: 14.6 + 5.9 + 10 + 11 = 41.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Aqylon Nexus LtdAQYLON 41.4/100Thin evidence · provisional54% evidence ASLEEP 12.7/35 Revenue 30.8% · PAT -52.5% · OPM change -2377.7 pp 48% evidence 16.8/25 ROCE 39.2% · OPM — 80% evidence 8.7/20 P/E 168.9× · PEG — 15% evidence 3.2/20 RS sector -41.3% · RS bench -74.1% · 1Y -68.5%0 of 10 weeks ahead 70% evidence
Exact sum: 12.7 + 16.8 + 8.7 + 3.2 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20Kaveri Seed Company LtdKSCL 41.2/100Mixed-negative evidence82% evidence ASLEEP 18.1/35 Revenue 15.9% · PAT 5% · OPM change 3 pp 65% evidence 12.6/25 ROCE 18.8% · OPM -15% 100% evidence 5.1/20 P/E 13.6× · PEG 2.98 100% evidence 5.4/20 RS sector -17.2% · RS bench -18.7% · 1Y -30.4%5 of 11 weeks ahead 70% evidence
Exact sum: 18.1 + 12.6 + 5.1 + 5.4 = 41.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21TruAlt Bioenergy LtdTRUALT 40.8/100Mixed-negative evidence63% evidence ASLEEP 11.1/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence 9.4/25 ROCE 10.8% · OPM 21% 100% evidence 10.3/20 P/E 23.2× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence
Exact sum: 11.1 + 9.4 + 10.3 + 10 = 40.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Delta Corp LtdDELTACORP 38.6/100Mixed-negative evidence77% evidence ASLEEP 11.2/35 Revenue -6.5% · PAT -66.4% · OPM change -5 pp 83% evidence 9.6/25 ROCE 5% · OPM 17% 95% evidence 12.5/20 P/E 18.9× · PEG — 50% evidence 5.3/20 RS sector -18.1% · RS bench -11.6% · 1Y -28.9%6 of 10 weeks ahead 70% evidence
Exact sum: 11.2 + 9.6 + 12.5 + 5.3 = 38.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Shipping Corporation of India Land & Assets LtdSCILAL 33.7/100Adverse evidence68% evidence ASLEEP 15.6/35 Revenue 27.3% · PAT 100% · OPM change -284.4 pp 62% evidence 4.7/25 ROCE 1.3% · OPM -349.6% 95% evidence 9.2/20 P/E 66.6× · PEG — 15% evidence 4.2/20 RS sector -15.5% · RS bench -12.7% · 1Y -19.8%3 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 4.7 + 9.2 + 4.2 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Unitech LtdUNITECH 32.0/100Adverse evidence65% evidence ASLEEP 12.8/35 Revenue 59% · PAT 5% · OPM change -584 pp 62% evidence 6.1/25 ROCE 0.1% · OPM 184% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 3.1/20 RS sector -27.3% · RS bench -24.8% · 1Y -42.1%3 of 12 weeks ahead 100% evidence
Exact sum: 12.8 + 6.1 + 10 + 3.1 = 32 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Stanley Lifestyles LtdSTANLEY 31.5/100Adverse evidence70% evidence TURNING 8.4/35 Revenue -1.6% · PAT -55.5% · OPM change -5.2 pp 83% evidence 10.3/25 ROCE 6.4% · OPM 14.9% 95% evidence 9.5/20 P/E 62.7× · PEG — 15% evidence 3.3/20 RS sector -43.7% · RS bench -23.7% · 1Y -53.6%3 of 10 weeks ahead 70% evidence
Exact sum: 8.4 + 10.3 + 9.5 + 3.3 = 31.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26RattanIndia Enterprises LtdRTNINDIA 29.3/100Adverse evidence62% evidence ASLEEP 13.8/35 Revenue 5.4% · PAT -80% · OPM change 19 pp 65% evidence 1.6/25 ROCE -4.8% · OPM -6% 100% evidence 10.0/20 P/E — · PEG — 0% evidence 3.9/20 RS sector -32.1% · RS bench -23% · 1Y -45%6 of 10 weeks ahead 70% evidence
Exact sum: 13.8 + 1.6 + 10 + 3.9 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Embassy Developments LtdEMBDL 26.2/100Adverse evidence68% evidence BREAKING OUT 4.3/35 Revenue -20.6% · PAT -80% · OPM change -76.9 pp 83% evidence 3.6/25 ROCE -2.4% · OPM -76% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.3/20 RS sector -17.2% · RS bench -14.6% · 1Y -45.6%8 of 12 weeks ahead 100% evidence
Exact sum: 4.3 + 3.6 + 10 + 8.3 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Central Mine Planning & Design Institute LtdCMPDI 62.2/100Thin evidence · provisional38% evidence TURNING 22.3/35 Revenue — · PAT — · OPM change 8 pp 32% evidence 19.8/25 ROCE 38.1% · OPM 30% 95% evidence 10.1/20 P/E 26.2× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —3 of 3 weeks ahead 0% evidence
Exact sum: 22.3 + 19.8 + 10.1 + 10 = 62.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29FlySBS Aviation LtdFLYSBS 54.7/100Thin evidence · provisional41% evidence TURNING 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence 18.9/25 ROCE 32.5% · OPM 21% 95% evidence 11.4/20 P/E 13.3× · PEG — 15% evidence 9.0/20 RS sector — · RS bench -6.8% · 1Y 4.4%3 of 10 weeks ahead 25% evidence
Exact sum: 15.4 + 18.9 + 11.4 + 9 = 54.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Qualitek Labs Ltd544091 53.7/100Thin evidence · provisional29% evidence 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence 15.0/25 ROCE 11.9% · OPM 26% 76% evidence 9.8/20 P/E 33.6× · PEG — 15% evidence 11.6/20 RS sector — · RS bench 9.1% · 1Y — 25% evidence
Exact sum: 17.3 + 15 + 9.8 + 11.6 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
31Shree Vasu Logistics LtdSVLL 51.9/100Thin evidence · provisional48% evidence TURNING 18.4/35 Revenue — · PAT — · OPM change 2.6 pp 19% evidence 15.7/25 ROCE 12.9% · OPM 29% 95% evidence 8.9/20 P/E 144× · PEG — 15% evidence 8.9/20 RS sector -16.1% · RS bench 5.1% · 1Y -8.1%9 of 10 weeks ahead 70% evidence
Exact sum: 18.4 + 15.7 + 8.9 + 8.9 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
32Maagh Advertising & Marketing Services Ltd543624 49.6/100Thin evidence · provisional35% evidence 18.3/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence 9.0/25 ROCE -0.4% · OPM 55.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 12.3/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence
Exact sum: 18.3 + 9 + 10 + 12.3 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
33Indiqube Spaces Ltdthis pageINDIQUBE 49.3/100Thin evidence · provisional46% evidence ASLEEP 20.9/35 Revenue 36.9% · PAT 23.6% · OPM change 5 pp 62% evidence 9.6/25 ROCE 6.4% · OPM 62% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.8/20 RS sector — · RS bench -9.8% · 1Y -20.2%2 of 10 weeks ahead 25% evidence
Exact sum: 20.9 + 9.6 + 10 + 8.8 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Anzen India Energy Yield Plus TrustANZEN 47.7/100Thin evidence · provisional46% evidence ASLEEP 17.4/35 Revenue 76.8% · PAT 100% · OPM change -9 pp 62% evidence 8.9/25 ROCE 3.3% · OPM 75.5% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 11.4/20 RS sector — · RS bench 5.7% · 1Y 9.6%4 of 10 weeks ahead 25% evidence
Exact sum: 17.4 + 8.9 + 10 + 11.4 = 47.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
35Shree Rama Newsprint LtdRAMANEWS 44.6/100Thin evidence · provisional46% evidence 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence 5.7/25 ROCE 1.9% · OPM 8% 71% evidence 10.0/20 P/E — · PEG — 0% evidence 14.8/20 RS sector 7.4% · RS bench 10.5% · 1Y 8.8%11 of 12 weeks ahead to 2026-04-19 70% evidence
Exact sum: 14.1 + 5.7 + 10 + 14.8 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
36Tandhan Industries Ltd512062 42.6/100Thin evidence · provisional33% evidence TURNING 16.3/35 Revenue — · PAT -80% · OPM change — 50% evidence 6.3/25 ROCE -0.3% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —4 of 4 weeks ahead 0% evidence
Exact sum: 16.3 + 6.3 + 10 + 10 = 42.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Indiqube Spaces Ltd's share price today?

Indiqube Spaces Ltd trades at ₹174, −20.2% over the past year. The company is valued at ₹3,684 Cr. The stock sits at 39% of its 52-week range of ₹134–₹238, −3.4% versus its 200-day average. On the tape, the price is in a downtrend, 34 weeks in. — as of 31 July 2026.

What were Indiqube Spaces Ltd's latest quarterly results?

Indiqube Spaces Ltd reported revenue of ₹401 Cr and a net loss of ₹23.0 Cr for the Mar 26 quarter. Earnings per share were ₹−1.07. The operating margin was 62.0%, 5.0 pp higher than a year earlier. — as of 31 July 2026.

What is Indiqube Spaces Ltd's revenue?

Indiqube Spaces Ltd reported revenue of ₹401 Cr in the Mar 26 quarter, +35.0% year on year. For the full FY26 fiscal year, revenue was ₹1,451 Cr (+37.0%). Over the last 6 years revenue compounded at 35.0% a year. — as of 31 July 2026.

What is Indiqube Spaces Ltd's profit?

Indiqube Spaces Ltd earned ₹−23.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹−106 Cr. The operating margin ran 62.0% in the latest quarter. — as of 31 July 2026.

What is Indiqube Spaces Ltd's market cap?

Indiqube Spaces Ltd's market capitalisation is ₹3,684 Cr at a share price of ₹174. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

Does Indiqube Spaces Ltd pay a dividend?

No — Indiqube Spaces Ltd has recorded a dividend payout of 0% of profit in each of its last 7 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.

How is Indiqube Spaces Ltd performing?

Indiqube Spaces Ltd is in a downtrend, 34 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

Is Indiqube Spaces Ltd in an uptrend?

No — the price is in a downtrend (week 34 of stage 4), trading −3.4% versus its 200-day average and at 39% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Indiqube Spaces Ltd beating the market?

On recent form, yes — Indiqube Spaces Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.0 years the stock moved −20% against the NIFTY 500's +4% — behind the index over the full window. — as of 31 July 2026.

Will Indiqube Spaces Ltd's share price go up?

This page publishes no price forecast for Indiqube Spaces Ltd. What it measures instead: the share price is ₹174, the price is in a downtrend 34 weeks in. Direction is not something this site claims to know. — as of 31 July 2026.

Who owns Indiqube Spaces Ltd?

Promoters hold 60.1% of Indiqube Spaces Ltd, foreign institutions 2.2%, domestic institutions 14.3% and the public 23.4% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.

Does Indiqube Spaces Ltd have too much debt?

It carries real leverage — Indiqube Spaces Ltd's debt-to-equity is 10.11, and operating profit covers the interest bill 2×. FY26 borrowings were ₹5,207 Cr against equity of ₹515 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.

What is Indiqube Spaces Ltd's capex?

Indiqube Spaces Ltd spent ₹4,263 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1,885 Cr, with ₹96.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Indiqube Spaces Ltd's cash flow?

Indiqube Spaces Ltd generated ₹920 Cr of operating cash flow in FY26 and ₹−965 Cr of free cash flow after ₹1,885 Cr of capital spending. Reported profit that year was ₹−106 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Where is Indiqube Spaces Ltd in its business cycle?

Indiqube Spaces Ltd's FY26 operating margin was 61.0%, against a 7-year band of 10.0%–61.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 62.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Indiqube Spaces Ltd story?

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Indiqube Spaces Ltd a stock worth studying right now?

This is not investment advice. The machine read: Indiqube Spaces Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI